Skip to main content
. 2016 Nov 24;9:6987–6998. doi: 10.2147/OTT.S110985

Figure 4.

Figure 4

Kaplan–Meier survival analysis of BMI1 expression in the testing set and overall patients.

Notes: Higher expression of BMI1 was closely correlated with poor overall survival (A) and recurrence-free survival (B) in the testing set. Overall, patients with higher BMI1 expression also showed inferior overall survival (C) and recurrence-free survival (D). In the testing set and overall patients, the median duration of overall survival for patients with low and high expression of BMI1 was 22 and 6 months (P<0.001) and 24 and 5 months (P<0.001), respectively.